BASF to Enter Medical Foods Market in the US with DIEM LabsBASF to Enter Medical Foods Market in the US with DIEM Labs
BASF Corporation and Diem Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
November 3, 2017
1 Min Read
BASF Corporation and Diem Labs, LLC. have entered into a distribution agreement to commercialize BASF’s first U.S. medical food product for the dietary management of patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like